Press release
Allergy Surge and Advanced Therapies Propel Atopic Dermatitis Market to USD 14 Billion by 2029
Mordor Intelligence has published a new report on the Atopic Dermatitis Market, offering a comprehensive analysis of trends, growth drivers, and future projections.The Atopic Dermatitis Market is projected to be valued at USD 10 billion in 2024 and is anticipated to grow to USD 14 billion by 2029, with a compound annual growth rate (CAGR) of 7.18% during the forecast period (2024-2029). Driving market growth are the rising prevalence of allergic reactions, the significant impact of food allergies, and the growing issue of environmental pollution.
Report Overview - https://www.mordorintelligence.com/industry-reports/atopic-dermatitis-market
Key Trends Driving the Atopic Dermatitis Market
1. Rising Prevalence of Allergic Reactions
The growing incidence of allergic conditions, particularly food allergies, significantly contributes to the prevalence of atopic dermatitis. In the United States, approximately 32 million individuals, including 5.6 million children under 18, suffer from food allergies, with about 40% of these children allergic to multiple foods.
2. Environmental Pollution
Increasing environmental pollution exacerbates atopic dermatitis symptoms, as pollutants can trigger or worsen skin reactions. Urbanization and industrial activities have heightened exposure to pollutants, leading to a higher incidence of skin conditions.
3. Advancements in Treatment Options
Recent years have seen significant progress in atopic dermatitis treatments. For instance, in December 2021, the U.S. Food and Drug Administration (FDA) approved Adbry (tralokinumab-ldrm) for adults with moderate-to-severe atopic dermatitis, offering a new therapeutic option.
4. Increased Research and Development
Pharmaceutical companies are investing in research to develop more effective treatments with fewer side effects. This focus on innovation is expected to yield advanced therapies, enhancing patient outcomes and driving market growth.
Market Segmentation
1. By Drug Class
Corticosteroids: Commonly used anti-inflammatory agents for reducing skin inflammation and itching.
Calcineurin Inhibitors: Topical immunosuppressants that help control immune responses in the skin.
Biologics: Targeted therapies designed to interfere with specific components of the immune system.
Phosphodiesterase-4 (PDE-4) Inhibitors: Medications that reduce inflammation by inhibiting specific enzymes.
2. By Mode of Administration
Topical: Creams, ointments, and lotions applied directly to the skin.
Oral: Systemic medications taken by mouth.
Injectable: Biologic drugs administered via injection.
3. By Distribution Channel
Hospital Pharmacies: Dispense medications within hospital settings.
Retail Pharmacies: Community pharmacies providing over-the-counter and prescription medications.
Online Pharmacies: Digital platforms offering medication delivery services.
4. By Geography
North America: Largest market due to high prevalence and advanced healthcare infrastructure.
Europe: Significant market share with increasing awareness and treatment options.
Asia-Pacific: Fastest-growing market driven by rising prevalence and healthcare investments.
Middle East and Africa: Emerging market with growing healthcare access.
South America: Developing market with increasing awareness and diagnosis rates.
Get a Customized Report Tailored to Your Requirements.:- https://www.mordorintelligence.com/market-analysis/dermatological-drugs
Key Players
The atopic dermatitis market is competitive, with several key players contributing to its growth:
Pfizer Inc.
AbbVie Inc.
Bristol Myers Squibb:
Regeneron Pharmaceuticals, Inc.
Evelo Biosciences, Inc.
These companies are actively involved in research and development, strategic collaborations, and product launches to strengthen their market positions.
Conclusion
The global atopic dermatitis market is on a robust growth trajectory, driven by the rising prevalence of allergic reactions, environmental factors, and advancements in treatment options. With ongoing research and development, the introduction of innovative therapies is anticipated, offering improved outcomes for patients. As key players continue to invest in new product development and strategic initiatives, the market is expected to expand, providing enhanced solutions for managing atopic dermatitis worldwide.
Industry Related Reports:
France Aesthetic Devices Market: The report highlights the market share and trends in the France Aesthetic Medicine Market, segmented by product (Botulinum Toxin, Dermal Filler, Chemical Peel, Microdermabrasion, and Other Products) and end user (Aesthetic Clinics, Hospitals, and Other End Users).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/france-aesthetic-devices-market
Canine Atopic Dermatitis Market: The Canine Atopic Dermatitis Market is categorized by treatment type (Glucocorticoids, Immunosuppressants, Monoclonal Antibodies, and Other Treatment Types), route of administration (Topical, Oral, and Injectable), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/canine-atopic-dermatitis-market
Pruritus Therapeutic Market: The Pruritus Therapeutics Market is divided by product type (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, and Other Product Types), disease type (Atopic Dermatitis/Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell Lymphoma, and Other Disease Types), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/pruritus-therapeutic-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Allergy Surge and Advanced Therapies Propel Atopic Dermatitis Market to USD 14 Billion by 2029 here
News-ID: 3766453 • Views: …
More Releases for Dermatitis
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
Current research: Demand for Atopic Dermatitis Treatment Market rapidly growing …
Report Ocean released a report deciphering the Atopic Dermatitis Treatment Market report that provides in-depth analysis and crucial insights into key factors that are crucial to the success of the market.
The report is a systematic study of the market that provides key statistics on trends, analyst views, competitive landscapes, and key regions markets report is a comprehensive study. In this research report, key business trends and upcoming Atopic Dermatitis Treatment…
Contact Dermatitis - Pipeline Review and Insight, H1 2018
Market Research HUB has added a new report titled "Contact Dermatitis - Pipeline Review, H1 2018" which provides an overview of the Contact Dermatitis (Dermatology) pipeline landscape. Contact dermatitis is a type of skin inflammation that occurs when substances touching skin cause irritation or an allergic reaction. Signs and symptoms of contact dermatitis include red rash or bumps, dry, cracked, red patches, which may resemble a burn and pain or…
Atopic Dermatitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atopic Dermatitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis - Pipeline Review, H2 2017, provides an overview of the Atopic Dermatitis (Dermatology) pipeline landscape.
Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored…
Dermatitis Global Clinical Trials Review H2 2017
ReportsWeb.com published “Dermatitis Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
GlobalData's clinical trial report, "Dermatitis Global Clinical Trials Review, H2, 2017" provides an overview of Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatitis. Report includes an overview…
Dermatitis Global Clinical Trials Review, H2, 2017
MarketResearchReports.Biz presents this most up-to-date research on "Dermatitis Global Clinical Trials Review, H2, 2017"
View Full Report at: https://www.marketresearchreports.biz/reports/1306866/dermatitis-global-clinical-trials-review-h2-2017-market-research-reports.pdf
Description
Dermatitis Global Clinical Trials Review, H2, 2017
Summary
GlobalData's clinical trial report, Dermatitis Global Clinical Trials Review, H2, 2017" provides an overview of Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted…